Physician profile
Abigail Pickell
NPI 1437980521
$1,854.03
in general payments reported to CMS, 2019-2025
19 companies · $1,854 in 2025
The $1,854 reported for 2025 was more than what 92% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $1,854.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,786 · Education: $68.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,786.03 |
| Education | $68.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $349.03 | 2025 | Rybrevant, Carvykti, Erleada |
| Teleflex LLC | $268.09 | 2025 | Barrigel, Urolift |
| Sumitomo Pharma America, INC. | $248.01 | 2025 | Orgovyx, Gemtesa |
| Endo USA, INC. | $161.76 | 2025 | Xiaflex, Aveed |
| Bayer Healthcare Pharmaceuticals INC. | $130.72 | 2025 | |
| Urogen Pharma, INC. | $123.06 | 2025 | |
| Astellas Pharma US INC | $94.05 | 2025 | Xtandi |
| Novartis Pharmaceuticals Corporation | $82.36 | 2025 | |
| Antares Pharma, INC. | $62.50 | 2025 | Xyosted |
| Ferring Pharmaceuticals INC. | $55.86 | 2025 | Adstiladrin |
| Progenics Pharmaceuticals, INC. | $52.84 | 2025 | |
| Boston Scientific Corporation | $44.41 | 2025 | Axonics |
| Merck Sharp & Dohme LLC | $33.59 | 2025 | Keytruda, Welireg |
| Abbvie INC. | $33.09 | 2025 | |
| Convatec INC. | $31.51 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $27.80 | 2025 | Rivfloza |
| C. R. Bard, INC. & Subsidiaries | $19.79 | 2025 | Bard Urinary Drainage Bag |
| Tolmar, INC. | $18.30 | 2025 | Eligard, Jatenzo |
| Olympus America INC. | $17.26 | 2025 | Itind System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abigail Pickell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.